Advertisement!
Author Information Pack
Editorial Board
Submit article
Special Issue
Editor's selection process
Join as Reviewer/Editor
List of Reviewer
Indexing Information
Most popular articles
Purchase Single Articles
Archive
Free Online Access
Current Issue
Recommend this journal to your library
Advertiser
Accepted Articles
Search Articles
Email Alerts
FAQ
Contact Us
International Journal of Pediatric Nursing

Volume  5, Issue 2, May-August 2019, Pages 79-81
 

Review Article

A Review on Ebola Virus Disease

MP Venkatesan1, R Karthiga2

1Professor, Vinayaka Mission Research Foundation, Salem, Vinayaka Mission’s College of Nursing, Karaikal, Puducherry 609609 India. 2Nursing Officer, Government General Hospital, Karaikal, Puducherry 609602, India.

Choose an option to locate / access this Article:
60 days Access
Check if you have access through your login credentials.        PDF      |
|

Open Access: View PDF

DOI: DOI: http://dx.doi.org/10.21088/potj.0974.5777.5219.7

Abstract

Ebola, the killer virus caused Ebola Virus Disease (EVD) formerly known as Ebola Hemorrhagic Fever (EHF) has mostly affected the underdeveloped countries. The virus family Filoviridae, among that the latest outbreak is Zaire species. The virus is scary, but it’s also rare. You can get it only from direct contact with an infected person’s body fluids. Symptoms may appear anywhere from 2 to 21 days after exposure to Ebola. Diagnostic procedures as Antigen-capture enzyme-linked immune sorbent assay (ELISA) testing, IgM -ELISA, Polymerase chain reaction (PCR), Virus isolation used. No approved vaccine or medicine (e.g., antiviral drug) is available for Ebola. Recovery from Ebola depends on good supportive care and the patient’s immune response.

Keywords: Ebola viral disease; Ebola hemorrhagic fever; ELISA; PCR; Antiviral drug


Corresponding Author : M.P. Venkatesan